These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 29460650)

  • 1. A comparison of human natural monoclonal antibodies and aptamer conjugates for promotion of CNS remyelination: where are we now and what comes next?
    Perwein MK; Smestad JA; Warrington AE; Heider RM; Kaczor MW; Maher LJ; Wootla B; Kunbaz A; Rodriguez M
    Expert Opin Biol Ther; 2018 May; 18(5):545-560. PubMed ID: 29460650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.
    Mullin AP; Cui C; Wang Y; Wang J; Troy E; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
    Neurobiol Dis; 2017 Sep; 105():142-155. PubMed ID: 28576706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antibody rHIgM22 facilitates hippocampal remyelination and ameliorates memory deficits in the cuprizone mouse model of demyelination.
    Cui C; Wang J; Mullin AP; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
    Brain Res; 2018 Sep; 1694():73-86. PubMed ID: 29775564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Method of identifying natural antibodies for remyelination.
    Warrington AE; Rodriguez M
    J Clin Immunol; 2010 May; 30 Suppl 1(0 1):S50-5. PubMed ID: 20387101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remyelination-Promoting DNA Aptamer Conjugate Myaptavin-3064 Binds to Adult Oligodendrocytes In Vitro.
    Fereidan-Esfahani M; Yue WY; Wilbanks B; Johnson AJ; Warrington AE; Howe CL; Rodriguez M; Maher LJ
    Pharmaceuticals (Basel); 2020 Nov; 13(11):. PubMed ID: 33228043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remyelination induced by a DNA aptamer in a mouse model of multiple sclerosis.
    Nastasijevic B; Wright BR; Smestad J; Warrington AE; Rodriguez M; Maher LJ
    PLoS One; 2012; 7(6):e39595. PubMed ID: 22761835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promotion of remyelination by immunoglobulins: implications for the treatment of multiple sclerosis.
    Trebst C; Stangel M
    Curr Pharm Des; 2006; 12(2):241-9. PubMed ID: 16454740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligodendrocyte precursor cells as a therapeutic target for demyelinating diseases.
    Skaper SD
    Prog Brain Res; 2019; 245():119-144. PubMed ID: 30961866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A recombinant human IgM promotes myelin repair after a single, very low dose.
    Warrington AE; Bieber AJ; Ciric B; Pease LR; Van Keulen V; Rodriguez M
    J Neurosci Res; 2007 Apr; 85(5):967-76. PubMed ID: 17304578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-mediated remyelination: relevance to multiple sclerosis.
    Bieber A; Asakura K; Warrington A; Kaveri SV; Rodriguez M
    Mult Scler; 2000 Oct; 6 Suppl 2():S1-5; discussion S33. PubMed ID: 11188771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.
    Najm FJ; Madhavan M; Zaremba A; Shick E; Karl RT; Factor DC; Miller TE; Nevin ZS; Kantor C; Sargent A; Quick KL; Schlatzer DM; Tang H; Papoian R; Brimacombe KR; Shen M; Boxer MB; Jadhav A; Robinson AP; Podojil JR; Miller SD; Miller RH; Tesar PJ
    Nature; 2015 Jun; 522(7555):216-20. PubMed ID: 25896324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remyelination therapies for multiple sclerosis: optimizing translation from animal models into clinical trials.
    Sutiwisesak R; Burns TC; Rodriguez M; Warrington AE
    Expert Opin Investig Drugs; 2021 Aug; 30(8):857-876. PubMed ID: 34126015
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease.
    Wootla B; Denic A; Watzlawik JO; Warrington AE; Rodriguez M
    Mol Neurobiol; 2016 Oct; 53(8):5217-28. PubMed ID: 26409478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remyelination-promoting human IgMs: developing a therapeutic reagent for demyelinating disease.
    Warrington AE; Rodriguez M
    Curr Top Microbiol Immunol; 2008; 318():213-39. PubMed ID: 18219820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDGF is required for remyelination-promoting IgM stimulation of oligodendrocyte progenitor cell proliferation.
    Watzlawik JO; Warrington AE; Rodriguez M
    PLoS One; 2013; 8(2):e55149. PubMed ID: 23383310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pericytes in Multiple Sclerosis.
    Rivera FJ; Hinrichsen B; Silva ME
    Adv Exp Med Biol; 2019; 1147():167-187. PubMed ID: 31147878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid Hormone Potentially Benefits Multiple Sclerosis via Facilitating Remyelination.
    Zhang M; Ma Z; Qin H; Yao Z
    Mol Neurobiol; 2016 Sep; 53(7):4406-16. PubMed ID: 26243185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing therapeutic strategies to promote myelin repair in multiple sclerosis.
    Baldassari LE; Feng J; Clayton BLL; Oh SH; Sakaie K; Tesar PJ; Wang Y; Cohen JA
    Expert Rev Neurother; 2019 Oct; 19(10):997-1013. PubMed ID: 31215271
    [No Abstract]   [Full Text] [Related]  

  • 19. Biotherapies in multiple sclerosis: a step toward remyelination and neuroprotection?
    Dubessy AL; Zujovic V; Papeix C; Stankoff B
    Rev Neurol (Paris); 2014 Dec; 170(12):770-8. PubMed ID: 25459127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple Sclerosis: Basic and Clinical.
    Buzzard K; Chan WH; Kilpatrick T; Murray S
    Adv Neurobiol; 2017; 15():211-252. PubMed ID: 28674983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.